Crossmark

Reduced post-transplant cyclophosphamide doses in haploidentical hematopoietic cell transplantation for elderly patients with hematological malignancies

Crossref DOI link: https://doi.org/10.1038/s41409-022-01908-y

Published Online: 2022-12-30

Published Print: 2023-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Duléry, Rémy https://orcid.org/0000-0002-5024-1713
Goudet, Claire

Mannina, Daniele

Bianchessi, Antonio

Granata, Angela

Harbi, Samia

Maisano, Valerio

Chabannon, Christian https://orcid.org/0000-0002-3755-4889
Malard, Florent

Brissot, Eolia https://orcid.org/0000-0003-4471-418X
Sestili, Simona

Banet, Anne

Van de Wyngaert, Zoé

Belhocine, Ramdane

Ederhy, Stéphane

Castagna, Luca

Bramanti, Stefania

Blaise, Didier https://orcid.org/0000-0002-5684-9447
Mohty, Mohamad https://orcid.org/0000-0002-7264-808X
Fürst, Sabine

Devillier, Raynier https://orcid.org/0000-0002-4045-8310
License Information

Text and Data Mining valid from 2022-12-30

Version of Record valid from 2022-12-30
More Information

Article History

Received: 9 September 2022

Revised: 19 December 2022

Accepted: 21 December 2022

First Online: 30 December 2022

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below